… The dismal treatment outcomes of MDR and XDR tuberculosis highlight the urgent need for
… treatment regimens, and other adjunct treatment approaches to improve treatment outcomes. …

… are underway, and use of adjunct therapies is being explored for … the duration of therapy and
to treat multidrug-resistant … laboratory methods, and adjunct host-directed therapies, and we …

… However, other studies demonstrated a similar effect on glycemic control between the two
treatment regimens. The first three randomized, double-blinded, placebo-controlled studies …

… regimen to date, 7 the fibrin specific accelerated rt-PA, has never been tested without heparin,
the regimen … deserves to be considered as adjunctive therapy. In clinical practice, this may …

… regimens and other adjunct therapies will temporally help in the fight against the totally resistant
strains of M.tb, but even if the new treatment … The purpose of adjunct immunotherapies is …

… the treatment of motor PD symptoms; notwithstanding, a wide range of adjunct therapies are
currently available for the treatment of … Most patients are on 16-h regimens and only use the …

… Adjunctive therapy may help in controlling the adverse metabolic effects of T1DM and insulin
therapy, … of action and adverse effects of adjunctive therapies for T1DM, with a focus on the …

… will require an adjunctive agent within 1 year ≤ 30% of the … for adjunctive therapy for glaucoma
patients treated with a … Finally, to help improve patient compliance, an adjunctive regimen …

… However, compliance (the extent to which patients follow the instructions and treatment
regimens prescribed by health care professionals) is really not what we should be measuring. …

… We sought adjunctive therapies that may be effective for the treatment of immunocompetent
adult patients with bacterial CAP of any severity, who are not in septic shock. For each …